Description
VDBEST-50 Tablet contains Vildagliptin 50 mg, an oral antidiabetic medicine belonging to the dipeptidyl peptidase-4 (DPP-4) inhibitor class. Vildagliptin is used to improve blood glucose control in adults with type 2 diabetes mellitus when prescribed appropriately, alongside dietary management, physical activity and regular medical monitoring.
Vildagliptin helps regulate glucose-dependent insulin secretion and glucagon levels by prolonging the activity of incretin hormones. Depending on the patient’s clinical requirements, a doctor may prescribe it alone or with other antidiabetic medicines. Treatment suitability depends on the patient’s health status, liver and kidney function, concurrent medicines and approved prescribing information.
CardianCare focuses on cardiac and diabetic healthcare products for healthcare professionals and pharmaceutical business enquiries. Businesses searching for a Vildagliptin 50 mg Tablets manufacturer India can enquire about product availability, approved specifications, manufacturing-source details and applicable quality documentation.
For procurement teams researching a Vildagliptin 50 mg Tablets manufacturer and supplier India, key considerations include composition accuracy, product authorization, batch traceability, packaging specifications, shelf life and applicable regulatory requirements.
2. Key Ingredient
Composition:
Vildagliptin 50 mg
Vildagliptin is an oral antidiabetic agent classified as a DPP-4 inhibitor. The DPP-4 enzyme breaks down incretin hormones, including GLP-1 and GIP, which play a role in regulating blood glucose after meals.
By inhibiting DPP-4, vildagliptin prolongs incretin activity. This supports glucose-dependent insulin secretion and helps regulate glucagon secretion when blood glucose levels are elevated.
For businesses evaluating a Vildagliptin 50 mg pharmaceutical company India, procurement assessments should cover the exact composition, approved labelling, manufacturing source, product-specific authorization and relevant quality documentation.
Companies searching for a Vildagliptin 50 mg medicine manufacturer India should verify the actual manufacturing facility, applicable licences, batch-release documentation and regulatory status before entering a procurement arrangement.
3. Key Benefits
Potential clinical roles of vildagliptin, when prescribed appropriately, include:
Blood glucose management: Helps improve glycaemic control in adults with type 2 diabetes mellitus.
Glucose-dependent action: Supports insulin secretion in response to elevated glucose levels.
Glucagon regulation: Helps regulate glucagon secretion, contributing to blood glucose control.
Oral dosage form: Offers an oral treatment option for eligible patients.
Combination therapy option: May be prescribed with selected antidiabetic medicines when clinically appropriate.
Individualized diabetes care: Can form part of a broader management plan involving dietary measures, physical activity and regular monitoring.
The clinical response varies between patients. Vildagliptin is not a substitute for lifestyle management or medical follow-up, and its suitability must be determined by a healthcare professional.
Pharmaceutical buyers looking for a Vildagliptin 50 mg supplier India should verify product authenticity, availability, shelf life, packaging and supporting documentation.
A Vildagliptin 50 mg Tablet wholesaler and distributor India enquiry may include stock availability, minimum order quantities, distribution eligibility, applicable licences and commercial terms.
Businesses seeking a Vildagliptin 50 mg bulk supplier India can request details about available pack sizes, order requirements, batch traceability, storage conditions and quality documentation.
A Vildagliptin 50 mg pharmaceutical distributor India should confirm product authorization, availability and applicable distribution requirements before beginning commercial activities.
4. How Does It Work?
Vildagliptin inhibits the DPP-4 enzyme, which normally breaks down the incretin hormones GLP-1 and GIP.
By prolonging the activity of these hormones, vildagliptin supports glucose-dependent insulin secretion and helps regulate glucagon secretion when blood glucose is elevated. These effects contribute to improved blood glucose regulation in suitable adults with type 2 diabetes.
The risk of hypoglycaemia may be relatively low when vildagliptin is used alone, but it can increase when combined with insulin or sulfonylureas. The complete treatment plan should therefore be reviewed by the prescribing clinician.
5. Directions for Use
Dosage: Take only as prescribed by a qualified doctor. The appropriate dose depends on the patient’s clinical condition and prescribed treatment plan.
Administration: Follow the approved product label and the doctor’s or pharmacist’s instructions regarding food and administration.
Regular timing: Take the medicine consistently according to the prescribed schedule.
Liver function: Liver function assessment may be required before and during treatment according to the approved prescribing information.
Kidney function: Patients with kidney impairment may require an adjusted regimen or additional monitoring, depending on their condition and the applicable product information.
Missed dose: Follow the patient leaflet or consult a pharmacist. Do not take a double dose to compensate for a missed dose.
Lifestyle management: Continue recommended dietary measures, physical activity and blood glucose monitoring.
Treatment changes: Do not stop, substitute or combine antidiabetic medicines without medical advice.
Do not assume that the same dosage is appropriate for every patient. Follow the approved prescribing information for the specific product.
6. Possible Side Effects
Possible adverse effects associated with vildagliptin may include:
Dizziness
Headache
Tremor or weakness in some patients
Gastrointestinal symptoms
Hypoglycaemia, particularly when combined with insulin or sulfonylureas
Important warning signs
Possible pancreatitis: Persistent severe abdominal pain, especially if it radiates to the back, requires urgent medical assessment.
Liver-related symptoms: Unexplained nausea, loss of appetite, dark urine or yellowing of the skin or eyes should be reported promptly to a healthcare professional.
Allergic reactions: Facial or throat swelling, breathing difficulty or a severe allergic reaction requires emergency medical care.
Blistering skin reactions: Unusual blistering or severe skin reactions should be assessed promptly.
Hypoglycaemia: Sweating, shaking, confusion or unusual weakness may indicate low blood glucose, especially when other glucose-lowering medicines are used.
This list is not exhaustive. Consult the approved product information and seek medical advice about persistent or concerning symptoms.
7. Safety Information
Medical supervision: Use only under the guidance of a qualified healthcare professional.
Allergies: Do not use in patients with a known serious hypersensitivity to vildagliptin or any ingredient in the formulation.
Liver health: Liver function should be assessed and monitored as directed by the approved prescribing information. Vildagliptin may not be suitable for some patients with liver disease.
Kidney health: Discuss kidney impairment with the prescribing clinician, as the treatment regimen and monitoring requirements may differ.
Pancreatic health: Patients with a history of pancreatitis should discuss treatment suitability with their doctor.
Pregnancy and breastfeeding: Seek medical advice before use during pregnancy, when planning pregnancy or while breastfeeding.
Drug interactions: Inform the doctor about all prescription medicines, over-the-counter products and supplements, particularly insulin and sulfonylureas.
Hypoglycaemia: The risk may increase when vildagliptin is used with other glucose-lowering medicines.
Storage: Store in the original packaging according to the approved product label, protected from excessive heat and moisture and out of reach of children.
This information is educational and does not replace approved prescribing information or individualized medical advice.
8. B2B Pharmaceutical Business Enquiries
CardianCare is associated with cardiac and diabetic healthcare products. Pharmaceutical businesses can contact the company to confirm the current product portfolio, product availability and applicable commercial arrangements.
Businesses researching a Vildagliptin 50 mg PCD pharma franchise India opportunity can enquire about eligible products, territory availability, partner requirements and applicable commercial terms. Confirm whether a relevant programme is currently offered before making business commitments.
For a Vildagliptin 50 mg Tablets PCD pharma franchise enquiry, prospective partners can request information about product availability, order requirements, distribution eligibility, promotional policies and relevant documentation.
Companies exploring a Vildagliptin 50 mg Tablet PCD franchise should verify the current programme, eligible products, territory terms and licensing requirements directly with the company.
Businesses evaluating Vildagliptin 50 mg third party manufacturing India should first confirm whether the proposed company offers this service. Due diligence should cover manufacturing permissions, product approvals, applicable GMP compliance, minimum batch quantities and quality documentation.
A Vildagliptin 50 mg Tablet third party manufacturer India enquiry should include verification of the manufacturing facility, product-specific permissions, batch-release procedures, packaging specifications and quality systems.
Companies considering Vildagliptin 50 mg contract manufacturing India should confirm the proposed partner’s manufacturing capabilities, regulatory permissions, formulation specifications, quality responsibilities and contractual terms.
Contact CardianCare through its official website to enquire about current product availability and applicable pharmaceutical business opportunities. Manufacturer, supplier, franchise and manufacturing-service arrangements must be verified directly before being represented as available.
For more information about VDBEST-50 Tablet (Vildagliptin 50 mg), Click Here













Reviews
There are no reviews yet.